Cargando…

Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization

We have reported that short-term stimulation of primary human monocyte-derived macrophages (MDM) with interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α), i.e. M1 polarization, leads to a significant containment of virus replication. Here we show that M1-MDM restimulation with these cytokines 7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graziano, Francesca, Aimola, Giulia, Forlani, Greta, Turrini, Filippo, Accolla, Roberto S., Vicenzi, Elisa, Poli, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155284/ https://www.ncbi.nlm.nih.gov/pubmed/30250078 http://dx.doi.org/10.1038/s41598-018-32451-w

Ejemplares similares

Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1
por: Forlani, Greta, et al.
Publicado: (2017)

The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells
por: Forlani, Greta, et al.
Publicado: (2016)

The Puzzling Role of CXCR4 in Human Immunodeficiency Virus Infection
por: Vicenzi, Elisa, et al.
Publicado: (2013)

HTLV-1 HBZ Viral Protein: A Key Player in HTLV-1 Mediated Diseases
por: Baratella, Marco, et al.
Publicado: (2017)

Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1
por: Forlani, Greta, et al.
Publicado: (2019)

132 A Novel Pathway of Proviral HIV-1 Latency Regulated by Aminoacid Starvation and HDAC4
por: Poli, Guido, et al.
Publicado: (2014)

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
por: Delagrèverie, Héloïse M., et al.
Publicado: (2016)

The MHC Class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation
por: Abdallah, Rawan, et al.
Publicado: (2014)

Recent developments in human immunodeficiency virus-1 latency research
por: Chan, Chi Ngai, et al.
Publicado: (2013)

Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses
por: Forlani, Greta, et al.
Publicado: (2017)

The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators
por: Forlani, Greta, et al.
Publicado: (2013)

Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal
por: Hayes, Alexander M.L.
Publicado: (2020)

Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure
por: Ventura, John D.
Publicado: (2020)

Human Immunodeficiency Virus (HIV)-1 Integration Sites in Viral Latency
por: Rezaei, Simin D., et al.
Publicado: (2015)

The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T-Cell Lymphotropic Virus Type 1
por: Tosi, Giovanna, et al.
Publicado: (2011)

Host Restriction Factors Modulating HIV Latency and Replication in Macrophages
por: Pagani, Isabel, et al.
Publicado: (2022)

HIV-1 Latency in Monocytes/Macrophages
por: Kumar, Amit, et al.
Publicado: (2014)

HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models
por: Forlani, Greta, et al.
Publicado: (2021)

The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1
por: Forlani, Greta, et al.
Publicado: (2015)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients
por: Forlani, Greta, et al.
Publicado: (2019)

Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication
por: Orlandi, Chiara, et al.
Publicado: (2011)

MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to, and affecting Tax-2 intracellular localization
por: Orlandi, Chiara, et al.
Publicado: (2011)

CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
por: Accolla, Roberto S., et al.
Publicado: (2019)

Unveiling the Hidden Treasury: CIITA-Driven MHC Class II Expression in Tumor Cells to Dig up the Relevant Repertoire of Tumor Antigens for Optimal Stimulation of Tumor Specific CD4+ T Helper Cells
por: Forlani, Greta, et al.
Publicado: (2020)

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication
por: Miller, Leia K, et al.
Publicado: (2013)

Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
por: Raval, Goutham U, et al.
Publicado: (2015)

Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
por: Raval, Goutham U, et al.
Publicado: (2015)

Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
por: Raval, Goutham U, et al.
Publicado: (2015)

Sensing of HIV-1 by TLR8 activates human T cells and reverses latency
por: Meås, Hany Zekaria, et al.
Publicado: (2020)

Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes
Publicado: (1991)

Human Immunodeficiency Virus Type-1 (HIV-1) Transcriptional Regulation, Latency and Therapy in the Central Nervous System
por: Hokello, Joseph, et al.
Publicado: (2021)

Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency
por: Wang, Zhuo, et al.
Publicado: (2017)

Feline immunodeficiency virus latency
por: McDonnel, Samantha J, et al.
Publicado: (2013)

Impact of latency‐reversing agents on human macrophage physiology
por: Hany, Laurent, et al.
Publicado: (2022)

Human Immunodeficiency Virus-1 Latency Reversal via the Induction of Early Growth Response Protein 1 to Bypass Protein Kinase C Agonist-Associated Immune Activation
por: Wong, Lilly M., et al.
Publicado: (2022)

Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia
por: Forlani, Greta, et al.
Publicado: (2021)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication
por: Walker-Sperling, Victoria E., et al.
Publicado: (2016)

Reply to the Letter to the Editor: “Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine” by Francavilla B et al.: Lack of a strong oral mucosal immune response: rethinking the route of COVID-19 vaccine boost administration?
por: Azzi, Lorenzo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fmf39037kdknitc8r030bth9dt